INS and thyroid gland carcinoma: Metformin has been demonstrated to reduce the cell viability of thyroid carcinoma cells, blocking cell cycle progression and inducing apoptosis, reducing the insulin-stimulated cell proliferation of thyroid carcinoma cells and their cancer stem cells.